Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD
Denise van der Graaff, Shivani Chotkoe, Benedicte Y. De Winter, et al.
JHEP Reports (2021) Vol. 4, Iss. 2, pp. 100412-100412
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways
Olufunto O. Badmus, Sarah A. Hillhouse, Christopher D. Anderson, et al.
Clinical Science (2022) Vol. 136, Iss. 18, pp. 1347-1366
Open Access | Times Cited: 178
Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
Rong Li, Junyan Zou, Wei Ran, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 152
Treating NASH by targeting peroxisome proliferator-activated receptors
Bart Staels, Laura Butruille, Sven Francque
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1302-1316
Open Access | Times Cited: 44
Therapeutic management of metabolic dysfunction associated steatotic liver disease
Jing Zeng, Jian‐Gao Fan, Sven Francque
United European Gastroenterology Journal (2024) Vol. 12, Iss. 2, pp. 177-186
Open Access | Times Cited: 36
Steatotic liver disease
Mads Israelsen, Sven Francque, Emmanuel Tsochatzis, et al.
The Lancet (2024) Vol. 404, Iss. 10464, pp. 1761-1778
Closed Access | Times Cited: 30
Metabolic dysfunction-associated steatotic liver disease and the heart
Stan Driessen, Sven Francque, Stefan D. Anker, et al.
Hepatology (2023)
Open Access | Times Cited: 31
The Association between Vascular Abnormalities and Glaucoma—What Comes First?
Xiaosha Wang, Maoren Wang, Hanhan Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13211-13211
Open Access | Times Cited: 25
Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
Rafael Paternostro, Wilhelmus J. Kwanten, Benedikt Hofer, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 5, pp. 827-836
Open Access | Times Cited: 12
MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists
Michael Cooreman, Luisa Vonghia, Sven Francque
Diabetes Research and Clinical Practice (2024) Vol. 212, pp. 111688-111688
Closed Access | Times Cited: 10
Endotheliopathy in the metabolic syndrome: Mechanisms and clinical implications
Kunimaro Furuta, Xiaofang Tang, Shahidul Islam, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108372-108372
Open Access | Times Cited: 19
Emerging Therapeutic Targets for Portal Hypertension
Éric Felli, Yelidousi Nulan, Sonia Selicean, et al.
Current Hepatology Reports (2023) Vol. 22, Iss. 1, pp. 51-66
Open Access | Times Cited: 15
Oxidative stress, inflammation, and steatosis elucidate the complex dynamics of HgCl2 induced liver damage in Channa punctata
Shefalee Singh, Shikha Dwivedi, Adeel Ahmad Khan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective
György Baffy, Piero Portincasa
Metabolites (2024) Vol. 14, Iss. 6, pp. 324-324
Open Access | Times Cited: 4
Liver sinusoidal endothelial cells: Friend or foe in metabolic dysfunction- associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis
Qingqing Dai, Quratul Ain, Namdev Seth, et al.
Digestive and Liver Disease (2025)
Open Access
Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
Pierre‐Emmanuel Rautou, Shivani Chotkoe, Louise Biquard, et al.
JHEP Reports (2025), pp. 101366-101366
Open Access
MASH to cirrhosis: bridging the gaps in MASLD management
Zouhir Gadi, Wilhelmus J. Kwanten, Luisa Vonghia, et al.
Acta Clinica Belgica (2025), pp. 1-10
Closed Access
Heart failure with preserved ejection fraction and non‐alcoholic fatty liver disease: new insights from bioinformatics
Anzhu Wang, Qiang Li, Zhuo Sun, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 1, pp. 416-431
Open Access | Times Cited: 15
Local fat content determines global and local stiffness in livers with simple steatosis
David Li, Paul A. Janmey, Rebecca G. Wells
FASEB BioAdvances (2023) Vol. 5, Iss. 6, pp. 251-261
Open Access | Times Cited: 5
Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease
Nahuel Aquiles García, Maiken Mellergaard, Hernán González‐King, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13326-13326
Open Access | Times Cited: 5
Research Progress on the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
志宇 高
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 1192-1198
Closed Access | Times Cited: 1
Is endothelin targeting finally ready for prime time?
Francesca Schinzari, Manfredi Tesauro, Carmine Cardillo
Clinical Science (2024) Vol. 138, Iss. 11, pp. 635-644
Closed Access | Times Cited: 1
Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation
Guoliang Yin, Hongyi Liang, Yiran Cheng, et al.
Chemico-Biological Interactions (2024) Vol. 405, pp. 111306-111306
Closed Access | Times Cited: 1
Portal hypertension is a key determinant of the risk for liver-related events in non-alcoholic fatty liver disease
Rafael Paternostro, Wilhelmus J. Kwanten, Thomas Reiberger
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. e102-e104
Open Access | Times Cited: 6
Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-alcoholic Fatty Liver Disease
Nahuel Aquiles García, Maiken Mellergaard, Hernán González‐King, et al.
(2023)
Open Access | Times Cited: 2
The liver sinusoid in chronic liver disease: NAFLD and NASH
Wilhelmus J. Kwanten, Sven Francque
Elsevier eBooks (2024), pp. 263-284
Closed Access
Page 1 - Next Page

Scroll to top